Cirrhosis Study to Assess Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis (RED-C-3131)
Study Details
View study details on clinicaltrials.gov.
Locations
- San Francisco
Clinical Trial FAQs
Information for patients and study volunteers, including frequently asked questions.